Literature DB >> 25765526

Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy.

Ja Young Kim1, Young Kyung Lim1, Tae Hyun Kim1, Kwang Hyun Cho1, Sang Hyoun Choi2, Hojin Jeong3, Dae Woong Kim1, Jung Hoon Park1, Dong Ho Shin1, Se Byeong Lee1, Sang Soo Kim1, Joo-Young Kim1, Dae Yong Kim1, Joong-Won Park1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25765526     DOI： 10.3109/0284186X.2015.1009637

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  9 in total

1.  The evolving evidence for the efficacy and safety of charged particle therapy for hepatocellular carcinoma-a commentary.

Authors:  Jillian Gunther; Sunil Krishnan
Journal:  Ann Transl Med       Date:  2015-12

Review 2.  Proton Therapy in the Management of Hepatocellular Carcinoma.

Authors:  Jana M Kobeissi; Lara Hilal; Charles B Simone; Haibo Lin; Christopher H Crane; Carla Hajj
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

3.  Dosimetric Comparison of Plans for Photon- or Proton-Beam Based Radiosurgery of Liver Metastases.

Authors:  Gracinda Mondlane; Michael Gubanski; Pehr A Lind; Thomas Henry; Ana Ureba; Albert Siegbahn
Journal:  Int J Part Ther       Date:  2016-12-30

4.  Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma.

Authors:  Tae Hyun Kim; Joong-Won Park; Bo Hyun Kim; Dae Yong Kim; Sung Ho Moon; Sang Soo Kim; Ju Hee Lee; Sang Myung Woo; Young-Hwan Koh; Woo Jin Lee; Chang-Min Kim
Journal:  Oncotarget       Date:  2017-12-19

Review 5.  Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.

Authors:  Stephanie K Schaub; Pehr E Hartvigson; Michael I Lock; Morten Høyer; Thomas B Brunner; Higinia R Cardenes; Laura A Dawson; Edward Y Kim; Nina A Mayr; Simon S Lo; Smith Apisarnthanarax
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

Review 6.  Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness.

Authors:  Che-Yu Hsu; Chun-Wei Wang; Ann-Lii Cheng; Sung-Hsin Kuo
Journal:  World J Gastrointest Oncol       Date:  2019-08-15

7.  Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer.

Authors:  Tae Hyun Kim; Keun Seok Lee; Sung Hoon Sim; Yeon-Joo Kim; Dae Yong Kim; Heejung Chae; Eun-Gyeong Lee; Jai Hong Han; So Youn Jung; Seeyoun Lee; Han Sung Kang; Eun Sook Lee
Journal:  Front Oncol       Date:  2021-11-03       Impact factor: 6.244

8.  Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.

Authors:  Tae Hyun Kim; Joong-Won Park; Bo Hyun Kim; Eun Sang Oh; Sang Hee Youn; Sung Ho Moon; Sang Soo Kim; Sang Myung Woo; Young-Hwan Koh; Woo Jin Lee; Dae Yong Kim
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

Review 9.  Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers.

Authors:  Lucia Cerrito; Brigida Eleonora Annicchiarico; Roberto Iezzi; Antonio Gasbarrini; Maurizio Pompili; Francesca Romana Ponziani
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.